Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (1625)	6/26/2006 3:49:10 AM
From: Robohogs	Read Replies (1) \| Respond to of 1834

It would be interesting to see what the FDA might require in this case also - probably some form of diffusion analysis? Coming from a non-scientific chap. Jon

To: DewDiligence_on_SI who wrote (1625)	6/26/2006 2:51:57 PM
From: NeuroInvestment	Respond to of 1834

<< I used to split 20mg Prozac capsules to save money because I was self-pay and the 10mg capsules cost almost the same amount as the 20mg ones. ... But my main point is that splitting capsules isn’t all that cumbersome if the economic incentive is there.>> You're not passive or lazy. A lot of people are, and are not going to go to the trouble. <<This would make an interesting lawsuit to follow and handicap. Can you recall a similar case being litigated?>> No. It certainly would be. Harry NeuroInvestment